
Jana A. Hines
Examiner (ID: 19289, Phone: (571)272-0859 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1641 |
| Total Applications | 1224 |
| Issued Applications | 527 |
| Pending Applications | 173 |
| Abandoned Applications | 536 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20472001
[patent_doc_number] => 20260014219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-15
[patent_title] => COMPOSITION FOR INHIBITING REDUCTION OF TESTOSTERONE AND/OR DIHYDROTESTOSTERONE
[patent_app_type] => utility
[patent_app_number] => 19/338284
[patent_app_country] => US
[patent_app_date] => 2025-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19338284
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/338284 | COMPOSITION FOR INHIBITING REDUCTION OF TESTOSTERONE AND/OR DIHYDROTESTOSTERONE | Sep 23, 2025 | Abandoned |
Array
(
[id] => 20458285
[patent_doc_number] => 20260007705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => PROBIOTIC COMPOSITIONS FOR PRODUCTION OF DOPAMINE
[patent_app_type] => utility
[patent_app_number] => 19/329122
[patent_app_country] => US
[patent_app_date] => 2025-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329122
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/329122 | PROBIOTIC COMPOSITIONS FOR PRODUCTION OF DOPAMINE | Sep 14, 2025 | Pending |
Array
(
[id] => 19770283
[patent_doc_number] => 20250051709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => AUTOMATED BIOREACTOR WITH FOAM COLLECTOR
[patent_app_type] => utility
[patent_app_number] => 18/933216
[patent_app_country] => US
[patent_app_date] => 2024-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/933216 | AUTOMATED BIOREACTOR WITH FOAM COLLECTOR | Oct 30, 2024 | Pending |
Array
(
[id] => 19996758
[patent_doc_number] => 20250134980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/921691
[patent_app_country] => US
[patent_app_date] => 2024-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 334
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/921691 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Oct 20, 2024 | Pending |
Array
(
[id] => 19641250
[patent_doc_number] => 20240415770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => METHODS AND SYSTEMS FOR FORMING STABLE DROPLETS
[patent_app_type] => utility
[patent_app_number] => 18/815388
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815388
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/815388 | METHODS AND SYSTEMS FOR FORMING STABLE DROPLETS | Aug 25, 2024 | Pending |
Array
(
[id] => 19801811
[patent_doc_number] => 20250067736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => MULTI-ANTIGEN DIAGNOSTIC FOR DETECTING LYME DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/814445
[patent_app_country] => US
[patent_app_date] => 2024-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18814445
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/814445 | Multi-antigen diagnostic for detecting lyme disease | Aug 22, 2024 | Issued |
Array
(
[id] => 19830963
[patent_doc_number] => 20250082749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => Vaccine Adjuvant
[patent_app_type] => utility
[patent_app_number] => 18/808565
[patent_app_country] => US
[patent_app_date] => 2024-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808565
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/808565 | Vaccine Adjuvant | Aug 18, 2024 | Pending |
Array
(
[id] => 19614983
[patent_doc_number] => 20240400663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof
[patent_app_type] => utility
[patent_app_number] => 18/807840
[patent_app_country] => US
[patent_app_date] => 2024-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18807840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/807840 | Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof | Aug 15, 2024 | Pending |
Array
(
[id] => 19544278
[patent_doc_number] => 20240361314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND FOR PREDICTING LYME DISEASE SPIROCHETE ELIMINATION AFTER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/767084
[patent_app_country] => US
[patent_app_date] => 2024-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18767084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/767084 | COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND FOR PREDICTING LYME DISEASE SPIROCHETE ELIMINATION AFTER TREATMENT | Jul 8, 2024 | Pending |
Array
(
[id] => 19641428
[patent_doc_number] => 20240415948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => MENINGOCOCCAL B RECOMBINANT VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/746742
[patent_app_country] => US
[patent_app_date] => 2024-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18746742
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/746742 | MENINGOCOCCAL B RECOMBINANT VACCINE | Jun 17, 2024 | Pending |
Array
(
[id] => 19631141
[patent_doc_number] => 20240409590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => ALPHA-HEMOLYSIN VARIANTS WITH ALTERED CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 18/746842
[patent_app_country] => US
[patent_app_date] => 2024-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18746842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/746842 | ALPHA-HEMOLYSIN VARIANTS WITH ALTERED CHARACTERISTICS | Jun 17, 2024 | Pending |
Array
(
[id] => 19447333
[patent_doc_number] => 20240307463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 18/737799
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/737799 | COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | Jun 6, 2024 | Abandoned |
Array
(
[id] => 19631140
[patent_doc_number] => 20240409589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/678030
[patent_app_country] => US
[patent_app_date] => 2024-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18678030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/678030 | MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES | May 29, 2024 | Pending |
Array
(
[id] => 19449289
[patent_doc_number] => 20240309419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHODS FOR CONTROLLING PROTEASE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/672093
[patent_app_country] => US
[patent_app_date] => 2024-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/672093 | METHODS FOR CONTROLLING PROTEASE PRODUCTION | May 22, 2024 | Pending |
Array
(
[id] => 19448943
[patent_doc_number] => 20240309073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/645135
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 430
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18645135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/645135 | METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF | Apr 23, 2024 | Pending |
Array
(
[id] => 19642912
[patent_doc_number] => 20240417432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => Antigenic OspA Polypeptides
[patent_app_type] => utility
[patent_app_number] => 18/640574
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640574 | Antigenic OspA Polypeptides | Apr 18, 2024 | Pending |
Array
(
[id] => 19387919
[patent_doc_number] => 20240277789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => DIETARY SUPPLEMENT COMPOSITION FOR TREATING AND MANAGING ACNE
[patent_app_type] => utility
[patent_app_number] => 18/633805
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633805
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/633805 | Dietary supplement composition for treating and managing acne | Apr 11, 2024 | Issued |
Array
(
[id] => 19479809
[patent_doc_number] => 20240327851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => METHODS AND COMPOSITIONS FOR IMPROVING ENGINEERED MICROBES THAT FIX NITROGEN
[patent_app_type] => utility
[patent_app_number] => 18/632573
[patent_app_country] => US
[patent_app_date] => 2024-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/632573 | METHODS AND COMPOSITIONS FOR IMPROVING ENGINEERED MICROBES THAT FIX NITROGEN | Apr 10, 2024 | Pending |
Array
(
[id] => 20562034
[patent_doc_number] => 12564624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Ostrich antibody for bacterial infectious diseases
[patent_app_type] => utility
[patent_app_number] => 18/632343
[patent_app_country] => US
[patent_app_date] => 2024-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 5659
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/632343 | Ostrich antibody for bacterial infectious diseases | Apr 10, 2024 | Issued |
Array
(
[id] => 20288553
[patent_doc_number] => 20250313796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => APPARATUS AND METHOD FOR ISOLATING INDIVIDUAL COLONIES THROUGH AUTOMATIC MULTI-CHANNEL STREAKING IN HIGH-PRESSURE ENVIRONMENT
[patent_app_type] => utility
[patent_app_number] => 18/625237
[patent_app_country] => US
[patent_app_date] => 2024-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18625237
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/625237 | APPARATUS AND METHOD FOR ISOLATING INDIVIDUAL COLONIES THROUGH AUTOMATIC MULTI-CHANNEL STREAKING IN HIGH-PRESSURE ENVIRONMENT | Apr 2, 2024 | Pending |